Annual Drug Patent Expirations for AUSTEDO+XR
Austedo Xr is a drug marketed by Teva and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
Drug patent litigation for AUSTEDO XR.
This drug has twenty patent family members in eighteen countries.
The generic ingredient in AUSTEDO XR is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
